Skip to main content
Erschienen in: Rheumatology International 6/2012

01.06.2012 | Short Communication

Adult-onset Still’s disease and chronic recurrent multifocal osteomyelitis: a hitherto undescribed manifestation of autoinflammation

verfasst von: J. Rech, B. Manger, B. Lang, G. Schett, M. Wilhelm, J Birkmann

Erschienen in: Rheumatology International | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Still’s disease and chronic recurrent multifocal osteomyelitis (CRMO) are febrile rheumatic diseases of unknown etiology, which predominantly affect children but can also have their initial manifestation in adults. Both can present as intermittent, relapsing episodes and are considered potential candidates within the expanding spectrum of autoinflammatory disorders, although no genetic abnormalities have been described for either of them. Here, we describe a man with an initial manifestation of abacterial multifocal osteitis at the age of 41. During a relapsing–remitting course of his illness, he increasingly developed symptoms of adult-onset Still’s disease (AOSD), and the diagnosis was established according to the Yamaguchi criteria. When treated with anakinra, not only the acute symptoms disappeared promptly, but also the osteitis went into complete remission. This is to our knowledge the first description of a simultaneous occurrence of these two manifestations of autoinflammation in adulthood.
Literatur
1.
Zurück zum Zitat Fautrel B (2008) Adult-onset still disease. Best Pract Res Clin Rheum 22:773–792CrossRef Fautrel B (2008) Adult-onset still disease. Best Pract Res Clin Rheum 22:773–792CrossRef
2.
Zurück zum Zitat Ferguson PJ, El-Shanti HI (2007) Autoinflammatory bone disorders. Curr Opin Rheumatol 19:492–498PubMedCrossRef Ferguson PJ, El-Shanti HI (2007) Autoinflammatory bone disorders. Curr Opin Rheumatol 19:492–498PubMedCrossRef
3.
Zurück zum Zitat Eleftheriou D, Gerschman T, Sebire N, Woo P, Pilkington CA, Brogan PA (2010) Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology 49:1505–1512PubMedCrossRef Eleftheriou D, Gerschman T, Sebire N, Woo P, Pilkington CA, Brogan PA (2010) Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology 49:1505–1512PubMedCrossRef
4.
Zurück zum Zitat Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A et al (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360:2426–2437PubMedCrossRef Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A et al (2009) An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med 360:2426–2437PubMedCrossRef
5.
Zurück zum Zitat Klein AK, Horneff G (2010) Rückbildung der Schwerhörigkeit bei einer Patientin mit Muckle-Wells-Syndrom unter Therapie mit Anakinra. Klin Padiatr 222:266–268PubMedCrossRef Klein AK, Horneff G (2010) Rückbildung der Schwerhörigkeit bei einer Patientin mit Muckle-Wells-Syndrom unter Therapie mit Anakinra. Klin Padiatr 222:266–268PubMedCrossRef
6.
Zurück zum Zitat De Koning HD, Bodar EJ, van der Meer JWM, Simon A (2007) Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 37:137–148PubMedCrossRef De Koning HD, Bodar EJ, van der Meer JWM, Simon A (2007) Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum 37:137–148PubMedCrossRef
Metadaten
Titel
Adult-onset Still’s disease and chronic recurrent multifocal osteomyelitis: a hitherto undescribed manifestation of autoinflammation
verfasst von
J. Rech
B. Manger
B. Lang
G. Schett
M. Wilhelm
J Birkmann
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 6/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2020-x

Weitere Artikel der Ausgabe 6/2012

Rheumatology International 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.